SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Pickert Curtis (Last) (First) (Middle) 1301 CONCORD TERRACE (Street) SUNRISE FL 33323 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 02/13/2023	3. Issuer Name and Ticker or Trading Symbol Pediatrix Medical Group, Inc. [ MD ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) EVP, Chief Operating Officer	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	29,246(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan. 8,284 shares vest on March 1, 2023, 1,542 shares vest on June 1, 2023, 8,167 shares vest on March 1, 2024, 3,083 shares vest on June 1, 2024 and 8,170 shares vest on March 1, 2025.

Remarks:

See Exhibit 24.1 - Power of Attorney

	/s/ Mary Ann E. Moore, Attorney-in-Fact	02/22/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

POWER OF ATTORNEY
For Executing Forms 3, 4, and 5

	Know all men by these presents, that the undersigned hereby appoints each of
Mary Ann E. Moore and C. Marc Richards, with full power of substitution, the
true and lawful attorneys-in-fact to:

(1)	execute for and on behalf of the undersigned SEC Forms 3, 4, and 5 relating
to the undersigneds interest in the Companys securities, in accordance with
Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules
thereunder;

(2)	do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete the execution of any such Form 3, 4,
or 5 and the timely filing of such form with the United States Securities and
Exchange Commission and any other appropriate authority; and

(3)	take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of the attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by the attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as the attorney-in-fact may approve in his
discretion.

The undersigned hereby grants to the above attorneys-in-fact full power and
authority to do and perform all and every act and thing whatsoever requisite,
necessary and proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorneys-in-fact, shall lawfully
do or cause to be done by virtue of this Power of Attorney and the rights and
powers herein granted.  The undersigned acknowledges that the above
attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming any of the undersigneds responsibilities to comply
with Sections 13(d) or 16 of the Securities Exchange Act of 1934, as amended.

	The authority of Mary Ann E. Moore and C. Marc Richards under this Power of
Attorney shall continue until the undersigned is no longer required to file
Forms 3, 4, or 5 with regard to the undersigneds ownership of or transactions in
securities of the Company, unless earlier revoked in writing.

	IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 9th day of February 2023.



/s/ Curtis Pickert, M.D.
Curtis Pickert, M.D.